Automated manufacturing for scalable, sustainable & cost-effective cell therapy commercialisation

In this presentation, delivered at BioProcessing International/Cell and Gene Therapy International 2025, Jahid Hasan, Programme Head of Cell Delivery at the CGT Catapult, highlights how automated manufacturing platforms can enable scalable, sustainable and cost-effective cell therapy commercialisation.

Watch the Webinar

Please provide your details to gain access.

The Cell and Gene Therapy Catapult takes your data very seriously. By using this form you are consenting to the processing of your personal data as per ourprivacy policy.